Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections

Intensive Care Medicine

Volumn 40, Issue 2, 2014, Pages 192-201

  Grimaldi, David ^a,b,c,d   Le Bourhis, Lionel ^e,f,g   Sauneuf, Bertrand ^a   Dechartres, Agnès ^c,h   Rousseau, Christophe ^b,c   Ouaaz, Fatah ^b,c   Milder, Maud ^e,f,g   Louis, Delphine ^e,f,g   Chiche, Jean Daniel ^a,b,c   Mira, Jean Paul ^a,b,c   Lantz, Olivier ^e,f,g   Pène, Frédéric ^a,b,c  

^a AP HP ^*  (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE HOSPITALIER DE VERSAILLES   (France)

^e INSTITUT CURIE   (France)

^f PSL RESEARCH UNIVERSITY   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h HÔTEL DIEU   (France)

Author keywords

Innate like lymphocytes; Nosocomial infection; Sepsis induced immunosuppression; Septic shock

Indexed keywords

ADULT; AGED; BACTERIAL INFECTION; CRITICAL ILLNESS; FEMALE; HUMAN; IMMUNOLOGY; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MUCOSA; NATURAL KILLER CELL; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 84893875610     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3163-x     Document Type: Article

References (36)

1. Treiner E, Lantz O (2006) CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol 18:519-526 (Pubitemid 44311447)
2. Bendelac A, Bonneville M, Kearney JF (2001) Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1:177-186 (Pubitemid 33741955)
3. Bonneville M, Scotet E (2006) Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 18:539-546 (Pubitemid 44311448)
4. Kawachi I, Maldonado J, Strader C, Gilfillan S (2006) MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol 176:1618-1627 (Pubitemid 43134306)
5. Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T (2006) Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol 7:987-994 (Pubitemid 44263913)
6. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, Levy E, Dusseaux M, Meyssonnier V, Premel V, Ngo C, Riteau B, Duban L, Robert D, Huang S, Rottman M, Soudais C, Lantz O (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11:701-708
7. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D, Milder M, Le Bourhis L, Soudais C, Treiner E, Lantz O (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117:1250-1259
8. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O (2011) Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32:212-218
9. Grimaldi D (2011) Bacterial sepsis induces a profound depletion in circulating mucosal-associated invariant T (MAIT) lymphocytes (Abstract). Intensive Care Med 37 (Suppl 1):1005
10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530-538 (Pubitemid 36523666)
11. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272 (Pubitemid 32405897)
12. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med 171:388-416
13. Anderson JR, Cain KC, Gelber RD (1983) Analysis of survival by tumor response. J Clin Oncol 1:710-719 (Pubitemid 14202071)
14. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509
15. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O'Hair RA, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, McCluskey J (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491:717-723
16. Cosgrove C, Ussher JE, Rauch A, Gartner K, Kurioka A, Huhn MH, Adelmann K, Kang YH, Fergusson JR, Simmonds P, Goulder P, Hansen TH, Fox J, Gunthard HF, Khanna N, Powrie F, Steel A, Gazzard B, Phillips RE, Frater J, Uhlig H, Klenerman P (2013) Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121:951-961
17. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, Fleming V, Flint J, Willberg CB, Bengsch B, Seigel B, Ramamurthy N, Zitzmann N, Barnes EJ, Thevanayagam J, Bhagwanani A, Leslie A, Oo YH, Kollnberger S, Bowness P, Drognitz O, Adams DH, Blum HE, Thimme R, Klenerman P (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 107:3006-3011
18. Asehnoune K, Roquilly A, Abraham E (2012) Innate immune dysfunction in trauma patients: from pathophysiology to treatment. Anesthesiology 117:411-416
19. Grimaldi D, Louis S, Pene F, Sirgo G, Rousseau C, Claessens YE, Vimeux L, Cariou A, Mira JP, Hosmalin A, Chiche JD (2011) Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intensive Care Med 37:1438-1446
20. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859-1866
21. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746-2752
22. Guignant C, Venet F, Planel S, Demaret J, Gouel-Cheron A, Nougier C, Friggeri A, Allaouchiche B, Lepape A, Monneret G (2013) Increased MerTK expression in circulating innate immune cells of patients with septic shock. Intensive Care Med 39:1556-1564
23. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Cheron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F (2011) Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 15:R99
24. Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260-268
25. Georgel P, Radosavljevic M, Macquin C, Bahram S (2011) The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol 48:769-775
26. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J, Winata E, Swarbrick GM, Chua WJ, Yu YY, Lantz O, Cook MS, Null MD, Jacoby DB, Harriff MJ, Lewinsohn DA, Hansen TH, Lewinsohn DM (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8:e1000407
27. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529 (Pubitemid 40477062)
28. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-525 (Pubitemid 40477061)
29. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7:978-986 (Pubitemid 44263912)
30. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, Imamura M, Kaneko Y, Okawara A, Miyazaki Y, Gomez-Velasco A, Rogers P, Dahesh S, Uchiyama S, Khurana A, Kawahara K, Yesilkaya H, Andrew PW, Wong CH, Kawakami K, Nizet V, Besra GS, Tsuji M, Zajonc DM, Kronenberg M (2011) Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12:966-974
31. Leung B, Harris HW (2011) NKT cells: the culprits of sepsis? J Surg Res 167:87-95
32. Venet F, Bohe J, Debard AL, Bienvenu J, Lepape A, Monneret G (2005) Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 33:2836-2840 (Pubitemid 41816419)
33. Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M, Ayala A (2008) Regulatory T cell populations in sepsis and trauma. J Leuk Biol 83:523-535 (Pubitemid 351966861)
34. Deknuydt F, Roquilly A, Cinotti R, Altare F, Asehnoune K (2013) An in vitro model of mycobacterial granuloma to investigate the immune response in brain-injured patients. Crit Care Med 41:245-254
35. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. New Engl J Med 361:1570-1583
36. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Monneret G (2004) Increased percentage of CD4+ CD25+ regulatory T cells during septic shock is due to the decrease of CD4+ CD25- lymphocytes. Crit Care Med 32:2329-2331 (Pubitemid 39491817)